• Vivesto to hold live-streamed business update on November 24

    November 12, 2025

  • Vivesto resolves on a fully secured rights issue of approximately SEK 53.8 million, subject to approval by an Extraordinary General Meeting

    November 20, 2025

  • Annual report 2024

    April 8, 2025
    (Only distributed in Swedish)

  • Notice of Extraordinary General Meeting in Vivesto AB

    November 20, 2025

Vivesto licenses Apealea to China’s Zhida Pharmaceutical

March 18, 2025

Interim Report Q3 2025 (in Swedish)

Vivesto published its Q3 report for 2025 on November 20, 2025, at 08.00 am CET.

The Share

Annual Report 2024